|
1
|
Xu P, Zhou Q and Xu J: Mechanism of
thrombocytopenia in COVID-19 patients. Ann Hematol. 99:1205–1208.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Phan LT, Nguyen TV, Luong QC, Nguyen TV,
Nguyen HT, Le HQ, Nguyen TT, Cao TM and Pham QD: Importation and
human-to-human transmission of a novel coronavirus in Vietnam. N
Engl J Med. 382:872–874. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Holshue ML, DeBolt C, Lindquist S, Lofy
KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural
A, et al: First case of 2019 novel coronavirus in the United
States. N Engl J Med. 382:929–936. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chan JF, Yuan S, Kok KH, Wang KK, Chu H,
Yang J, Xing F, Liu J, Yip CC, Poon RW, et al: A familial cluster
of pneumonia associated with the 2019 novel coronavirus indicating
person-to-person transmission: A study of a family cluster. Lancet.
395:514–523. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chen N, Zhou M, Dong X, Qu J, Gong F, Han
Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: A descriptive study. Lancet. 365:507–513.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Lui L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics
of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J
and Yang M: Mechanisms involved in the development of
thrombocytopenia in patients with COVID-19. Thromb Res.
193:110–115. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wool GD and Miller JL: The impact of
COVID-19 disease on platelets and coagulation. Pathobiology.
88:15–27. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao
S, Long D and Yu L: Association between platelet parameters and
mortality in coronavirus disease 2019: Retrospective cohort study.
Platelets. 31:490–496. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Martinic Z, Skopec B, Rener K, Mavric M,
Vovko T, Jereb M and Lukic M: Severe immune thrombocytopenia in a
critically ill COVID-19 patient. Int J Infect Dis. 99:269–271.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bao C, Tao X, Cui W, Yi B, Pan T, Young KH
and Qian W: SARS-CoV-2 induced thrombocytopenia as an important
biomarker significantly correlated with abnormal coagulation
function, increased intravascular blood clot risk and mortality in
COVID-19 patients. Exp Hematol Oncol. 9(16)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bomhof G, Mutsaers PGNJ, Leebeek FWG, Te
Boekhorst PAW, Hofland J, Croles FN and Jansen AJG:
COVID-19-associated immune thrombocytopenia. Br J Haematol.
190:e61–e64. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Humber S, Razanamahery J, Payet-Revest C,
Bouiller K and Chirouze C: COVID-19 as a cause of immune
thrombocytopenia. Med Mal Infect. 50:459–460. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
De la Cruz-Benito B, Rivas-Pollmar MI,
Alvarez Roman MT, Trelles-Martinez R, Martin-Salces M, Lazaro-del
Campo P, Ramirez-Lopez A, Garcia-Bacenilla S, Cebanu T, Acuna-Butta
P, et al: Paradoxical effect of SARS-CoV-2 infection in patients
with immune thrombocytopenia. Br J Haematol. 192:973–977.
2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Maquet J, Lafaurie M, Sommet A and Moulis
G: Thrombocytopenia is independently associated with poor outcome
in patients hospitalized for COVID-19. Br J Haematol.
190:e276–e279. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pavord S, Thachil J, Hunt BJ, Murphy M,
Lowe G, Laffan M, Makris M, Newland AC, Provan D, Grainger JD and
Hill QA: Practical guidance for the management of adults with
immune thrombocytopenia during the COVID-19 pandemic. Br J
Haematol. 189:1038–1043. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hu Z, Chen W, Liang W, Xu C, Sun W and Yi
Y: Severe exacerbation of immune thrombocytopenia and COVID-19: The
favorable response to corticosteroid-based therapy-a case report.
Ann Hematol. 1–3. 2020.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
21
|
Mahevas M, Moulis G, Andres E, Riviere E,
Garzano M, Crickx E, Guillotin V, Malphettes M, Galicier L, Noel N,
et al: Clinical characteristics, management and outcome of
COVID-19-associated immune thrombocytopenia: A French multicentre
series. Br J Haematol. 190:e224–e229. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bhattacharjee S and Banerjee M: Immune
thrombocytopenia secondary to COVID-19: A systematic review. SN
Compr Clin Med: Sep 19, 2020 (Epub ahead of print).
|
